Insulin-degrading enzyme haplotypes affect insulin levels but not dementia risk

Neurodegenerative Diseases

Volumn 3, Issue 6, 2007, Pages 320-326

  Marlowe, Lauren ^a   Peila, Rita ^a,b   Benke, Kelly Suzanne ^c   Hardy, John ^a   White, Lon R ^b   Launer, Lenore J ^a   Myers, Amanda ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alzheimer's disease; Epidemiology; IDE; Insulin

Indexed keywords

INSULIN; INSULINASE;

AGED; ALZHEIMER DISEASE; ARTICLE; ASIAN AMERICAN; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FOLLOW UP; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; TIME SERIES ANALYSIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; COHORT STUDIES; DEMENTIA, VASCULAR; GENOTYPE; HAPLOTYPES; HUMANS; INSULIN; INSULYSIN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 33845935327     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000097300     Document Type: Article

References (26)

1. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, et al: Hyperinsulinemia as an independent risk factor for ischemic heart disease. New Engl J Med 1996;334:952-957.
2. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005;365:141, 528.
3. Craft S, Watson GS: Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004;3:169-178.
4. Duckworth WC, Bennett RG, Hamel FG: Insulin degradation: progress and potential. Endocr Rev 1998;19:608-624.
5. Galli J, Fakhrai-Rad H, Kamel A, Marcus C, Norgren S, et al: Pathophysiological and genetic characterization of the major diabetes locus in GK rats. Diabetes 1999;48:2463-2470.
6. Kurochkin IV: Insulin-degrading enzyme: embarking on amyloid destruction. Trends Biochem Sci 2001;26:421-425.
7. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, et al: Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003;100:4162-4167.
8. Farris W, Mansourian S, Leissring MA, Eckman EA, Bertram L, et al: Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid-beta protein. Am J Pathol 2004;164:1425-1434.
9. Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, et al: The Finland United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. 1. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 2000;67:1174-1185.
10. Bertram L, Blacker D, Mullin K, Keeney D, Jones J, et al: Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 2000;290:2302-2303.
11. Gu HF, Efendic S, Nordman S, Ostenson CG, Brismar K, et al: Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels. Diabetes 2004;53:2137-2142.
12. Meigs JB, Panhuysen CI, Myers RH, Wilson PW, Cupples LA: A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes 2002;51:833-840.
13. Karamohamed S, Demissie S, Volcjak J, Uu C, Heard-Costa N, et al: Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes 2003;52:1562-1567.
14. Prince JA, Feuk L, Gu HF, Johansson B, Gatz M, et al: Genetic variation in a haplotype block spanning IDE influences Alzheimer disease. Hum Mutat 2003;22:363-371.
15. Blomqvist ME, Chalmers K, Andreasen N, Bogdanovic N, Wilcock GK, et al: Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Neurobiol Aging 2005;26:795-802.
16. Abraham R, Myers A, Wavrant-DeVrieze F, Hamshere ML, Thomas HV, et al: Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet 2001;109:646-652.
17. Peila R, Rodriguez BL, Launer LJ: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 2002;51:1256-1262.
18. Peila R, Rodriguez BL, White LR, Launer LJ: Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology 2004;63:228-233.
19. White L, Petrovitch H, Ross GW, Masaki KH, Abbott RD, et al: Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA 1996;276:955-960.
20. Qin ZS, Niu T, Liu JS: Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet 2002;71:1242-1247.
21. Schaid DJ: Evaluating associations of haplotypes with traits. Genet Epidemiol 2004;127:348-364.
22. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-434.
23. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, et al: Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003;55:56-65.
24. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington, America Psychiatric Association, 1987.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
26. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R: Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.